Novavax (NVAX) Operating Leases (2020 - 2025)
Novavax (NVAX) posted quarterly Operating Leases of $21.4 million for Q4 2025, down 72.03% year-over-year from $76.7 million in Q4 2024, and down 72.03% quarter-over-quarter from $76.7 million in Q4 2024.
Novavax (NVAX) Operating Leases (2020 - 2025) Analysis & Trends
Novavax's Operating Leases history runs 6 years deep, the most recent figure standing at $21.4 million for Q4 2025.
- In Q4 2025, Operating Leases fell 72.03% year-over-year to $21.4 million; the TTM figure through Dec 2025 stood at $21.4 million (down 72.03% YoY), while the FY2025 annual figure was $21.4 million, down 72.03% from the prior year.
- Operating Leases for Q4 2025 stood at $21.4 million, down from $76.7 million in the prior quarter.
- The five-year high for Operating Leases was $84.5 million in Q4 2023, with the low at $21.4 million in Q4 2025.
- The 5-year median for Operating Leases is $76.7 million (2024), against an average of $60.6 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases surged 107.9% in 2022, then plunged 72.03% in 2025.
- Novavax's Operating Leases stood at $39.1 million in 2021, then soared by 107.9% to $81.3 million in 2022, then advanced by 3.91% to $84.5 million in 2023, then declined by 9.25% to $76.7 million in 2024, then slumped by 72.03% to $21.4 million in 2025.
- Business Quant data shows NVAX's Operating Leases at $21.4 million in Q4 2025, $76.7 million in Q4 2024, and $84.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.45 Mn |
| Dec 31, 2024 | 76.68 Mn |
| Dec 31, 2023 | 84.50 Mn |
| Dec 31, 2022 | 81.32 Mn |
| Dec 31, 2021 | 39.12 Mn |
| Dec 31, 2020 | 50.21 Mn |